HEPSA

Statement from the ASHM COVID-19 Taskforce regarding the prioritisation of COVID-19 vaccines for people living with blood-borne virus-related chronic liver disease

Statement from the ASHM COVID-19 Taskforce regarding the prioritisation of COVID-19 vaccines for people living with blood-borne virus-related chronic liver disease , Australia - 21p.

Designed to provide available, relevant information to clinicians and other healthcare providers to optimise the health and wellbeing of people living with BBV related chronic liver disease during the COVID-19 pandemic.

Related term: Coronavirus


English

Transmission: Prevention/infection control General reference: Other communicable diseases

Powered by

Koha

Provided by

Hepatitis SA

Hosted by

Catalyst

Hepatitis SA acknowledges and respects the Kaurna people as the traditional custodians of the unceded ancestral land from which we work. We pay our respects to elders past and present.